toxoflavin has been researched along with Sarcoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alemany, R; Calabuig-Fariñas, S; Felipe-Abrio, I; Martín-Broto, J; Martinez-Font, E; Obrador-Hevia, A; Ramos, R; Terrasa, J; Vögler, O | 1 |
1 other study(ies) available for toxoflavin and Sarcoma
Article | Year |
---|---|
Disruption of TCF/β-Catenin Binding Impairs Wnt Signaling and Induces Apoptosis in Soft Tissue Sarcoma Cells.
Topics: Antineoplastic Agents; Apoptosis; beta Catenin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Doxorubicin; Drug Synergism; Humans; Protein Binding; Pyrimidinones; Sarcoma; TCF Transcription Factors; Triazines; Wnt Signaling Pathway | 2017 |